A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL

NCT03969134 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
86
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of York